Lobbying client

AXOGEN, INC.

Company focused on developing medical solutions to restore peripheral nerve function

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 3 of its records are shown together here.

Filings
30
Filed by
3
Reported in-house
—
Reported by firms
$374,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2010 to 2026

Filings

30 filings, newest first.
Filing Filed by Amount
2nd Quarter - Report
2nd Quarter 2026
LKB STRATEGIES LLC $15,000 reported
1st Quarter - Report
1st Quarter 2026
LKB STRATEGIES LLC $15,000 reported
1st Quarter - Termination
1st Quarter 2026
JEFFREY J. KIMBELL & ASSOCIATES, INC. $15,000 reported
4th Quarter - Report
4th Quarter 2025
LKB STRATEGIES LLC $15,000 reported
4th Quarter - Report
4th Quarter 2025
JEFFREY J. KIMBELL & ASSOCIATES, INC. $15,000 reported
3rd Quarter - Report
3rd Quarter 2025
LKB STRATEGIES LLC $15,000 reported
3rd Quarter - Report
3rd Quarter 2025
JEFFREY J. KIMBELL & ASSOCIATES, INC. $15,000 reported
Registration
3rd Quarter 2025
JEFFREY J. KIMBELL & ASSOCIATES, INC. — reported
2nd Quarter - Report
2nd Quarter 2025
LKB STRATEGIES LLC $15,000 reported
1st Quarter - Report
1st Quarter 2025
LKB STRATEGIES LLC $15,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
LKB STRATEGIES LLC 18 $215,000
M.J. SIMON & COMPANY, LLC 5 $114,000
JEFFREY J. KIMBELL & ASSOCIATES, INC. 3 $45,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 24
Medical/Disease Research/Clinical Labs MED 4
Veterans VET 1

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.